Adherence to Antihypertensive Medication in Post-Stroke Patients: Patterns, Barriers, and Clinical Outcomes in a Prospective Cohort Study
Keywords:
Adherence, Anti-Hypertensive Medicines, Post-StrokeAbstract
Background: Medication adherence is crucial for secondary stroke prevention, yet non-adherence remains a significant challenge. This study evaluates adherence patterns, identifies key barriers, and assesses clinical outcomes in post-stroke patients receiving antihypertensive therapy.
Methods: A prospective cohort study was conducted in a single tertiary care center, enrolling 150 post-stroke patients. Adherence was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8). Barriers to adherence were identified through structured questionnaires. Clinical outcomes, including blood pressure control, recurrent stroke, and cardiovascular events, were recorded over a 12-month follow-up. Statistical analyses included Chi-square tests, logistic regression, and Kaplan-Meier survival analysis.
Results: Only 36% of patients exhibited high adherence, while 32% had moderate and 32% had low adherence. Key barriers included forgetfulness (42%), fear of side effects (28%), and cost-related constraints (25%). Patients with low adherence had a 3.2-fold increased risk of recurrent stroke (p = 0.002). Blood pressure control was achieved in 85% of high-adherence patients versus 29% in the low-adherence group (p < 0.001).
Conclusion: Adherence to antihypertensive therapy remains suboptimal in post-stroke patients, contributing to poor clinical outcomes. Targeted interventions addressing barriers to adherence are essential to enhance secondary stroke prevention and improve patient survival
Downloads
References
Donkor E. S. (2018). Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life. Stroke research and treatment, 2018, 3238165. https://doi.org/10.1155/2018/3238165
Funakoshi, S., Kawazoe, M., Tada, K., Abe, M., & Arima, H. (2022). Blood Pressure Lowering for the Secondary Prevention of Stroke. Cardiology Discovery, 2(1), 51–57. https://doi.org/10.1097/cd9.0000000000000048
Hamrahian, S. M., Maarouf, O. H., & Fülöp, T. (2022). A Critical Review of Medication Adherence in Hypertension: Barriers and Facilitators Clinicians Should Consider. Patient preference and adherence, 16, 2749–2757. https://doi.org/10.2147/PPA.S368784
Lee, H. J., Jang, S. I., & Park, E. C. (2017). Effect of adherence to antihypertensive medication on stroke incidence in patients with hypertension: a population-based retrospective cohort study. BMJ open, 7(6), e014486. https://doi.org/10.1136/bmjopen-2016-014486
Kvarnström, K., Westerholm, A., Airaksinen, M., & Liira, H. (2021). Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics, 13(7), 1100. https://doi.org/10.3390/pharmaceutics13071100
Janežič, A., Locatelli, I., & Kos, M. (2017). Criterion validity of 8-item Morisky Medication Adherence Scale in patients with asthma. PloS one, 12(11), e0187835. https://doi.org/10.1371/journal.pone.0187835
Oh S. W. (2021). Medication Adherence and Effective Management of Hypertension. Korean journal of family medicine, 42(2), 89–90. https://doi.org/10.4082/kjfm.42.2E
Souliotis, K., Giannouchos, T. V., Golna, C., & Liberopoulos, E. (2022). Assessing forgetfulness and polypharmacy and their impact on health-related quality of life among patients with hypertension and dyslipidemia in Greece during the COVID-19 pandemic. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation, 31(1), 193–204. https://doi.org/10.1007/s11136-021-02917-y
Baryakova, T. H., Pogostin, B. H., Langer, R., & McHugh, K. J. (2023). Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nature reviews. Drug discovery, 22(5), 387–409. https://doi.org/10.1038/s41573-023-00670-0
Peng, X., Wan, L., Yu, B. et al. The link between adherence to antihypertensive medications and mortality rates in patients with hypertension: a systematic review and meta-analysis of cohort studies. BMC Cardiovasc Disord 25, 145 (2025). https://doi.org/10.1186/s12872-025-04538-6
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

